Source:http://linkedlifedata.com/resource/pubmed/id/11896626
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2002-3-22
|
pubmed:abstractText |
The molecular basis for most non-HNPCC familial colorectal cancer cases is unknown, but there is increasing evidence that common genetic variants may play a role. We investigated the contribution of polymorphisms in two genes implicated in the pathogenesis of colorectal cancer, cyclin D1 (CCND1) and E-cadherin (CDH1), to familial and sporadic forms of the disease. The CCND1 870A/G polymorphism is thought to affect the expression of CCND1 through mRNA splicing and has been reported to modify the penetrance of HNPCC. Inactivation of E-cadherin is common in colorectal cancer, and truncating germline mutations have been reported to confer susceptibility to colorectal as well as diffuse gastric cancer. The -160A/C CDH1 polymorphism appears to affect expression of CDH1 and may therefore also confer an increased risk. We found a significantly higher frequency of CCND1 870A allele in 206 familial cases compared to 171 controls (P=0.03). Odds ratios in heterozygotes and homozygotes were 1.7 (95% CI: 1.0-2.66) and 1.8 (95% CI: 1.0-3.3) respectively. The difference was accounted for by an over-representation of A allele in non-HNPCC familial cases (P=0.007). Over-representation of the CCND1 A allele was also seen in sporadic colorectal cancer cases compared to controls but this did not attain statistical significance (P=0.08). No significant differences between the frequency of CDH1 -160A/C genotypes in familial, sporadic colorectal cancer cases and controls were seen, although a possible association between the low expressing A allele and right-sided tumours was detected in familial cases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0950-9232
|
pubmed:author |
pubmed-author:EvansD Gareth RDG,
pubmed-author:FisherSamantha ASA,
pubmed-author:HoulstonRichard SRS,
pubmed-author:JankowskiJanusz AJA,
pubmed-author:MacdonaldFionaF,
pubmed-author:MaherEamonn RER,
pubmed-author:NorburyGailG,
pubmed-author:PayneStewart JSJ,
pubmed-author:PorterTimothy RTR,
pubmed-author:RichardsFrances MFM,
pubmed-author:TomlinsonIanI
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1928-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11896626-Cadherins,
pubmed-meshheading:11896626-Case-Control Studies,
pubmed-meshheading:11896626-Colorectal Neoplasms,
pubmed-meshheading:11896626-Cyclin D1,
pubmed-meshheading:11896626-DNA, Neoplasm,
pubmed-meshheading:11896626-DNA Mutational Analysis,
pubmed-meshheading:11896626-DNA Primers,
pubmed-meshheading:11896626-Female,
pubmed-meshheading:11896626-Genetic Predisposition to Disease,
pubmed-meshheading:11896626-Genotype,
pubmed-meshheading:11896626-Humans,
pubmed-meshheading:11896626-Male,
pubmed-meshheading:11896626-Middle Aged,
pubmed-meshheading:11896626-Polymerase Chain Reaction,
pubmed-meshheading:11896626-Polymorphism, Genetic,
pubmed-meshheading:11896626-Risk Factors
|
pubmed:year |
2002
|
pubmed:articleTitle |
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
|
pubmed:affiliation |
Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|